Targeting Cellular Senescence with Liposome-Encapsulated Fisetin: Evidence of Senomorphic Effect
International Journal of Molecular Sciences · 02.08.2025 · 26 (15) · 7489
DOI: 10.3390/ijms26157489 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.08.2025. Verfasst von Agata Henschke und 5 weiteren Autor:innen. Beteiligte Einrichtung: NanoBioMedical Centre, Adam Mickiewicz University, Wszechnicy Piastowskiej 3, 61-614 Poznan, Poland. Hauptthemen laut MEDLINE: Liposomes, Cellular Senescence, Flavonoids, Senotherapeutics. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre of Poland.
Abstract (Originalsprache)
Cellular senescence is closely connected with cancer progression, recurrence, and metastasis. Senotherapy aims to soothe the harmful effects of senescent cells either by inducing their apoptosis (senolytic) or by suppressing the senescence-associated secretory phenotype (SASP) (senomorphic). Fisetin, a well-studied senotherapeutic drug, was selected for this study to evaluate its efficiency when delivered in a liposomal formulation. The experiment evaluated the impact of liposome-encapsulated fisetin on senescent cells induced by doxorubicin (DOX) from two cell lines: WI-38 (normal lung fibroblasts) and A549 (lung carcinoma). Senescence was characterized by SA-β-galactosidase (SA-β-gal) activity, proliferation, morphology, and secretion of pro-inflammatory interleukin 6 (IL-6) and interleukin 8 (IL-8). Due to fisetin’s hydrophobic nature, it was encapsulated in liposomes to enhance cellular delivery. Cellular uptake studies confirmed that the liposomes were effectively internalized by both senescent cell types. Treatment with fisetin-loaded liposomes revealed a lack of senolytic effects but showed senomorphic activity, as evidenced by a significant reduction in IL-6 and IL-8 secretion in senescent cells. The liposomal formulation enhanced fisetin’s therapeutic efficacy, showing comparable results even at the lowest tested concentration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NanoBioMedical Centre, Adam Mickiewicz University, Wszechnicy Piastowskiej 3, 61-614 Poznan, Poland.
- Biomedical Polymers Division, Research Institute for Materials Science and Technology (INTEMA), National University of Mar del Plata (UNMdP)-National Scientific and Technical Research Council (CONICET), Av. Colón 10850,…
- Soft Matter Nanotechnology Group, CIC biomaGUNE, Basque Research and Technology Alliance (BRTA), Paseo Miramón 182, San Sebastián, 20014 Guipúzcoa, Spain.
ORCID-Profile: Olena Ivashchenko, Emerson Coy
Förderung
- National Science Centre of Poland
Zitieren
APA
Henschke, A., Grześkowiak, B., Ivashchenko, O., Sánchez-Cerviño, M. C., Coy, E., & Moya, S. (2025). Targeting Cellular Senescence with Liposome-Encapsulated Fisetin: Evidence of Senomorphic Effect. International Journal of Molecular Sciences, 26(15), 7489. https://doi.org/10.3390/ijms26157489
Vancouver
Henschke A, Grześkowiak B, Ivashchenko O, Sánchez-Cerviño MC, Coy E, Moya S. Targeting Cellular Senescence with Liposome-Encapsulated Fisetin: Evidence of Senomorphic Effect. International Journal of Molecular Sciences. 2025;26(15):7489. doi:10.3390/ijms26157489
BibTeX
@article{Henschke2025,
author = {Henschke, Agata and Grześkowiak, Bartosz and Ivashchenko, Olena and Sánchez-Cerviño, María Celina and Coy, Emerson and Moya, Sergio},
title = {Targeting Cellular Senescence with Liposome-Encapsulated Fisetin: Evidence of Senomorphic Effect},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {15},
pages = {7489},
doi = {10.3390/ijms26157489}
}
EUVIMED